Feature

Dan Kastner wins Crafoord Prize in Polyarthritis


 

The Royal Swedish Academy of Sciences and the Crafoord Foundation in Lund has awarded Daniel Kastner, MD, PhD, its 2021 Crafoord Prize in Polyarthritis, “for establishing the concept of autoinflammatory diseases.” The prize, named after the donor Holger Crafoord because of his bout with severe rheumatoid arthritis toward the end of his life, is for 6 million Swedish kronor (approximately USD $700,000).

Dr. Kastner, scientific director at the U.S. National Human Genome Research Institute’s division of intramural research, received the award for identifying the mechanisms responsible for familial Mediterranean fever, tumor necrosis factor receptor–associated periodic syndrome, and other diagnoses within the group of autoinflammatory diseases.

“Dan Kastner is often called the father of autoinflammatory diseases, a title that he thoroughly deserves. His discoveries have taught us a great deal about the immune system and its functions, contributing to effective treatments that reduce the symptoms of diseases from which patients previously suffered enormously, sometimes leading to premature death,” Olle Kämpe, chair of the prize committee, said in a press announcement.

While the Crafoord Prize normally is awarded on a 3-year rotating basis for achievements in mathematics and astronomy, geosciences, and biosciences, the prize in polyarthritis is “only awarded when there has been scientific progress that motivates a prize,” according to the press release.

Recommended Reading

Etonogestrel implants may be bent, fractured by trauma or during sports
MDedge Internal Medicine
Teenage bone density declines following sleeve gastrectomy
MDedge Internal Medicine
LGBTQ+ youth issues include fertility counseling and foster care
MDedge Internal Medicine
New dietary guidelines omit recommended cuts to sugar, alcohol intake
MDedge Internal Medicine
Children’s hospitals grapple with wave of mental illness
MDedge Internal Medicine
AAP issues new guidelines for diagnosing, managing eating disorders
MDedge Internal Medicine
Data call for biologics trials in undertreated juvenile arthritis subtype
MDedge Internal Medicine
Moderna needs more kids for COVID vaccine trials
MDedge Internal Medicine
Bathing now more widely accepted as an eczema treatment strategy
MDedge Internal Medicine
Tofacitinib for RA misses the mark in safety study
MDedge Internal Medicine